You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Society for Immunotherapy of Cancer (SITC) consensus definitions for immune checkpoint inhibitor-associated immune-related adverse events (irAEs) terminology
|
|---|---|
| Published in |
Journal for Immunotherapy of Cancer, March 2023
|
| DOI | 10.1136/jitc-2022-006398 |
| Pubmed ID | |
| Authors |
Jarushka Naidoo, Catherine Murphy, Michael B Atkins, Julie R Brahmer, Stephane Champiat, David Feltquate, Lee M Krug, Javid Moslehi, M Catherine Pietanza, Joanne Riemer, Caroline Robert, Elad Sharon, Maria E Suarez-Almazor, Karthik Suresh, Michelle Turner, Jeffrey Weber, Laura C Cappelli |
X Demographics
The data shown below were collected from the profiles of 162 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 36 | 22% |
| Ireland | 12 | 7% |
| Spain | 8 | 5% |
| Italy | 6 | 4% |
| United Kingdom | 5 | 3% |
| France | 5 | 3% |
| Peru | 4 | 2% |
| Colombia | 3 | 2% |
| Belgium | 2 | 1% |
| Other | 17 | 10% |
| Unknown | 64 | 40% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 91 | 56% |
| Practitioners (doctors, other healthcare professionals) | 34 | 21% |
| Scientists | 31 | 19% |
| Science communicators (journalists, bloggers, editors) | 6 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 40 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 40 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Researcher | 7 | 18% |
| Other | 4 | 10% |
| Student > Doctoral Student | 4 | 10% |
| Student > Ph. D. Student | 4 | 10% |
| Professor | 3 | 8% |
| Other | 5 | 13% |
| Unknown | 13 | 33% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 17 | 43% |
| Immunology and Microbiology | 3 | 8% |
| Unspecified | 2 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 5% |
| Psychology | 1 | 3% |
| Other | 1 | 3% |
| Unknown | 14 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 148. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 May 2024.
All research outputs
#288,121
of 26,069,033 outputs
Outputs from Journal for Immunotherapy of Cancer
#54
of 3,557 outputs
Outputs of similar age
#6,839
of 428,752 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#2
of 111 outputs
Altmetric has tracked 26,069,033 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 98th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,557 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.8. This one has done particularly well, scoring higher than 97% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 428,752 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 111 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 98% of its contemporaries.